Free Trial

Maxim Group Forecasts Strong Price Appreciation for Nutex Health (NASDAQ:NUTX) Stock

Nutex Health logo with Medical background
Remove Ads

Nutex Health (NASDAQ:NUTX - Free Report) had its price target boosted by Maxim Group from $75.00 to $100.00 in a research report report published on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock.

Nutex Health Stock Up 15.1 %

NASDAQ:NUTX traded up $17.28 during mid-day trading on Tuesday, reaching $132.03. The stock had a trading volume of 244,391 shares, compared to its average volume of 54,462. The stock's 50 day simple moving average is $62.62 and its two-hundred day simple moving average is $41.92. Nutex Health has a 1-year low of $4.16 and a 1-year high of $134.53. The company has a market capitalization of $729.86 million, a price-to-earnings ratio of -14.07 and a beta of 0.27. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings results on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The business had revenue of $81.30 million during the quarter, compared to the consensus estimate of $81.13 million.

Remove Ads

Hedge Funds Weigh In On Nutex Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of America Corp DE grew its stake in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after buying an additional 2,043 shares during the last quarter. Beaird Harris Wealth Management LLC acquired a new stake in shares of Nutex Health in the 3rd quarter worth about $69,000. Northern Trust Corp bought a new stake in Nutex Health in the 4th quarter valued at about $200,000. Baader Bank Aktiengesellschaft bought a new position in Nutex Health in the 4th quarter worth about $206,000. Finally, Millennium Management LLC acquired a new stake in shares of Nutex Health in the fourth quarter valued at approximately $213,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Read More

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads